HR Execs on the Move


 
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.cardionomicinc.com
  • 2009 West Broadway Ave Ste 400, PMB 130
    Forest Lake, MN USA 55025
  • Phone: 651.964.0170

Executives

Name Title Contact Details

Similar Companies

Nexus

Nexus is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bacterin International

Bacterin International, Inc. is a Belgrade, MT-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Carelon

Carelon is a healthcare services company that provides connected healthcare solutions for better outcomes and experiences.

Versicolor Technologies

Versicolor Technologies has developed the world`s first cosmetic and therapeutic technology platform to address pigmentation and skin aging, by leveraging small molecule compounds produced naturally in the human microbiome.

Elemy

Every child is different. At Elemy, we believe care should never be one-size-fits-all. Chat with us about in-home, personalized care for your child.